[FORM 6-K Aluminum Corporation of China Limited People's Republic of China 100082 No. 62 North Xizhimen Street X Form 20-F X Yes 99.1 MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES Aluminum Corporation of China Limited Date July 3, 2018 By]
[W ashington FORM 8-A Amendment No. 4 FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES SINOVAC BIOTECH LTD. Antigua, West Indies Not Applicable (State or other jurisdiction (I.R.S. Employer Identification of incorporation or organization) Number) No. 15 Zhi Tong Road, Zhongguancun Science and Techno]
[FORM 6-K Aluminum Corporation of China Limited People's Republic of China 100082 No. 62 North Xizhimen Street X Form 20-F X Yes 99.1 MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES Aluminum Corporation of China Limited Date July 3, 2018 By]
[W ashington FORM 8-A Amendment No. 4 FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES SINOVAC BIOTECH LTD. Antigua, West Indies Not Applicable (State or other jurisdiction (I.R.S. Employer Identification of incorporation or organization) Number) No. 15 Zhi Tong Road, Zhongguancun Science and Techno]
[CERTIFICATE OF AMENDMENT OF AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF SEMILEDS CORPORATION 1. He is the duly elected and acting Chief Executive Officer of SemiLEDs Corporation, a Delaware corporation. 2. The Certificate of Incorporation of this corporation was originally filed with the De]
[Sinovac Raises $86.73 Million Through Private Placement Transaction · Vivo Capital and Advantech Capital Each Hold an Approximately 8.3% Stake in Sinovac After the Private Placement Transaction · Proceeds Will Be Used to Fund Improvement and Construction of Facilities for R&D Relating to Quality Con]
[CERTIFICATE OF AMENDMENT OF AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF SEMILEDS CORPORATION 1. He is the duly elected and acting Chief Executive Officer of SemiLEDs Corporation, a Delaware corporation. 2. The Certificate of Incorporation of this corporation was originally filed with the De]
[Sinovac Raises $86.73 Million Through Private Placement Transaction · Vivo Capital and Advantech Capital Each Hold an Approximately 8.3% Stake in Sinovac After the Private Placement Transaction · Proceeds Will Be Used to Fund Improvement and Construction of Facilities for R&D Relating to Quality Con]
[SCHEDULE 13D/A (Amendment No. 19)* SEMICONDUCTOR MANUFACTURING INTERNATIONAL CORPORATION (Name of Issuer) Common Shares, par value US$0.004 Per Share (Title of Class of Securities) 81663 N206 (CUSIP Number) Yu QIAN Legal Counsel Datang Telecom Technology & Industry Holdings Co., Ltd. No. 40 Xueyuan ]
